Italia markets close in 6 hours 54 minutes

Yield10 Bioscience Inc (M6X3.DU)

Dusseldorf - Dusseldorf Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
4,8360+4,6345 (+2.300,00%)
In data: 07:31PM CEST. Mercato aperto.
Schermo intero
Chiusura precedente0,2015
Aperto0,2015
Denaro0,0000 x N/D
Domanda0,0000 x N/D
Min-Max giorno0,1880 - 4,8360
Intervallo di 52 settimane0,1880 - 64,8000
VolumeN/D
Media Volume0
CapitalizzazioneN/D
Beta (mensile su 5 anni)N/D
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utili08 mag 2024 - 13 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina

    -On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025 -First field tests of stacked herbicide tolerant winter Camelina underway -Recent positive field tests demonstrate stacked herbicide traits in spring Camelina -Herbicide tolerance in Camelina supports large acreage production of low-carbon intensity feedstock oil for the biofuel market WOBURN, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”),

  • GlobeNewswire

    Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production

    Begins revenue generation for “Camelina Seed Genetics to Biofuel” platformWOBURN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the harvest of a majority of the winter and spring Camelina sativa ("Camelina”) grain produced under grower contracts in 2022/2023 has been completed. This harvest marks the establishment of the Company’s “Camelina Seed Genetics to Biofuel” platform,

  • GlobeNewswire

    Yield10 Bioscience to Present at the H.C. Wainwright 25th Annual Global Investment Conference

    WOBURN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference being held on September 11-13, 2023, at the Lotte New York Palace Hotel. President and Chief Executive Officer Oliver Peoples, Ph.D. will present a corporate overview that will also include a business update. The presentation will